Ballew Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,994
Closed -$233K 108
2024
Q3
$233K Buy
1,994
+22
+1% +$2.57K 0.16% 95
2024
Q2
$279K Buy
1,972
+304
+18% +$43K 0.18% 85
2024
Q1
$208K Buy
+1,668
New +$208K 0.14% 96